Roles of P53 in Extrinsic Factor-induced Liver Carcinogenesis

Overview

Journal Hepatoma Res

Date 2018 Aug 21

PMID 30123836

Citations 14

Authors

Tim Link

Tomoo Iwakuma

Affiliations

Soon will be listed here.

Abstract

Liver cancer remains one of the most common human cancers with a high mortality rate. Therapies for hepatocellular carcinoma (HCC) remain ineffective, due to the heterogeneity of HCC with regard to both the etiology and mutation spectrum, as well as its chemotherapy resistant nature; thus surgical resection and liver transplantation remain the gold standard of patient care. The most common etiologies of HCC are extrinsic factors. Humans have multiple defense mechanisms against extrinsic factor-induced carcinogenesis, of which tumor suppressors play crucial roles in preventing normal cells from becoming cancerous. The tumor suppressor is one of the most frequently mutated genes in liver cancer. p53 regulates expression of genes involved in cell cycle progression, cell death, and cellular metabolism to avert tumor development due to carcinogens. This review article mainly summarizes extrinsic factors that induce liver cancer and potentially have etiological association with p53, including aflatoxin B1, vinyl chloride, non-alcoholic fatty liver disease, iron overload, and infection of hepatitis viruses.

Citing Articles

Hepatic Iron Overload and Hepatocellular Carcinoma: New Insights into Pathophysiological Mechanisms and Therapeutic Approaches.

Chatzikalil E, Arvanitakis K, Kalopitas G, Florentin M, Germanidis G, Koufakis T Cancers (Basel). 2025; 17(3).

PMID: 39941760 PMC: 11815926. DOI: 10.3390/cancers17030392.

The Loss of an Orphan Nuclear Receptor NR2E3 Augments Wnt/β-catenin Signaling via Epigenetic Dysregulation that Enhances Sp1-β catenin-p300 Interactions in Hepatocellular Carcinoma.

Leung Y, Lee S, Wang J, Guruvaiah P, Rusch N, Ho S Adv Sci (Weinh). 2024; 11(29):e2308539.

PMID: 38790135 PMC: 11304255. DOI: 10.1002/advs.202308539.

Significance of 8-OHdG Expression as a Predictor of Survival in Colorectal Cancer.

Kang M, Jeong S, Park S, Nam S, Chung J, Kim K Cancers (Basel). 2023; 15(18).

PMID: 37760582 PMC: 10526191. DOI: 10.3390/cancers15184613.

p53 expression is associated with tumor stage, grade and subtype in patients with hepatocellular carcinoma.

Rahadiani N, Stephanie M, Perkasa A, Handjari D, Krisnuhoni E Mol Clin Oncol. 2023; 19(1):54.

PMID: 37323246 PMC: 10265582. DOI: 10.3892/mco.2023.2650.

Role of p53 suppression in the pathogenesis of hepatocellular carcinoma.

Choudhary H, Mandlik S, Mandlik D World J Gastrointest Pathophysiol. 2023; 14(3):46-70.

PMID: 37304923 PMC: 10251250. DOI: 10.4291/wjgp.v14.i3.46.

References

He Q, Cheng R, Sun Y, Feng D, Chen Z, Zheng H . Hepatocyte transformation and tumor development induced by hepatitis C virus NS3 c-terminal deleted protein. World J Gastroenterol. 2003; 9(3):474-8. PMC: 4621564. DOI: 10.3748/wjg.v9.i3.474. View

Feng D, Sun Y, Cheng R, Ouyang X, Zheng H . Effect of hepatitis C virus nonstructural protein NS3 on proliferation and MAPK phosphorylation of normal hepatocyte line. World J Gastroenterol. 2005; 11(14):2157-61. PMC: 4305787. DOI: 10.3748/wjg.v11.i14.2157. View

Shank R . Metabolic activation of mycotoxins by animals and humans: an overview. J Toxicol Environ Health. 1977; 2(6):1229-44. DOI: 10.1080/15287397709529526. View

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

Lemon S, Lerat H, Weinman S, Honda M . A transgenic mouse model of steatosis and hepatocellular carcinoma associated with chronic hepatitis C virus infection in humans. Trans Am Clin Climatol Assoc. 2000; 111:146-56; discussion 156-7. PMC: 2194357. View

Kew M . Hepatocellular carcinoma in African Blacks: Recent progress in etiology and pathogenesis. World J Hepatol. 2010; 2(2):65-73. PMC: 2999270. DOI: 10.4254/wjh.v2.i2.65. View

Kim H, Lee H, Yun Y . X-gene product of hepatitis B virus induces apoptosis in liver cells. J Biol Chem. 1998; 273(1):381-5. DOI: 10.1074/jbc.273.1.381. View

Ming L, Thorgeirsson S, Gail M, Lu P, Harris C, Wang N . Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China. Hepatology. 2002; 36(5):1214-20. DOI: 10.1053/jhep.2002.36366. View

Tarocchi M, Polvani S, Marroncini G, Galli A . Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis. World J Gastroenterol. 2014; 20(33):11630-40. PMC: 4155355. DOI: 10.3748/wjg.v20.i33.11630. View

10.

Schulze K, Imbeaud S, Letouze E, Alexandrov L, Calderaro J, Rebouissou S . Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets. Nat Genet. 2015; 47(5):505-511. PMC: 4587544. DOI: 10.1038/ng.3252. View

11.

Dragani T, Zocchetti C . Occupational exposure to vinyl chloride and risk of hepatocellular carcinoma. Cancer Causes Control. 2008; 19(10):1193-200. DOI: 10.1007/s10552-008-9188-8. View

12.

Niederau C, Lange S, Heintges T, Erhardt A, Buschkamp M, HURTER D . Prognosis of chronic hepatitis C: results of a large, prospective cohort study. Hepatology. 1998; 28(6):1687-95. DOI: 10.1002/hep.510280632. View

13.

Guyton K, Kensler T . Prevention of liver cancer. Curr Oncol Rep. 2002; 4(6):464-70. DOI: 10.1007/s11912-002-0057-4. View

14.

Tomita K, Teratani T, Suzuki T, Oshikawa T, Yokoyama H, Shimamura K . p53/p66Shc-mediated signaling contributes to the progression of non-alcoholic steatohepatitis in humans and mice. J Hepatol. 2012; 57(4):837-43. DOI: 10.1016/j.jhep.2012.05.013. View

15.

Yeh C, Chang M, Shyu W, Chang M, Yang P, Tsao M . Characterization of a HCV NS5A protein derived from a patient with hepatoma. Biochem Biophys Res Commun. 2005; 327(2):516-22. DOI: 10.1016/j.bbrc.2004.11.165. View

16.

Kang J, Jones C, Brothwell B . Toxicity associated with iron overload found in hemochromatosis: possible mechanism in a rat model. Clin Lab Sci. 1999; 11(6):350-4. View

17.

Cleary S, Jeck W, Zhao X, Chen K, Selitsky S, Savich G . Identification of driver genes in hepatocellular carcinoma by exome sequencing. Hepatology. 2013; 58(5):1693-702. PMC: 3830584. DOI: 10.1002/hep.26540. View

18.

Weng C, Hsieh Y, Tsai C, Chu Y, Ueng K, Liu Y . Relationship of insulin-like growth factors system gene polymorphisms with the susceptibility and pathological development of hepatocellular carcinoma. Ann Surg Oncol. 2010; 17(7):1808-15. DOI: 10.1245/s10434-009-0904-8. View

19.

Feng S, Li M, Zhang J, Liu S, Wang Q, Quan M . Regulation of HepG2 cell apoptosis by hepatitis C virus (HCV) core protein via the sirt1-p53-bax pathway. Virus Genes. 2015; 51(3):338-46. DOI: 10.1007/s11262-015-1253-2. View

20.

Grebely J, Page K, Sacks-Davis R, Schim van der Loeff M, Rice T, Bruneau J . The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. Hepatology. 2013; 59(1):109-20. PMC: 3972017. DOI: 10.1002/hep.26639. View